| P2093 | author name string | Bin Zhang | |
| | Xiaoying Liu | |
| | Chunyu Deng | |
| | Wei Shi | |
| | Yanhui Liu | |
| | Wenjian Wang | |
| | Zhixin Shan | |
| | Yunfeng Xia | |
| | Suxia Wang | |
| | Jianchao Ma | |
| | Xinling Liang | |
| | Lixia Xu | |
| | Ping Mei | |
| | Houqin Xiao | |
| | Shuangxin Liu | |
| | Yongzheng Liang | |
| | Zhiming Ye | |
| | Zhilian Li | |
| P2860 | cites work | A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer | Q24605866 |
| | Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes | Q24678613 |
| | The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development | Q28142247 |
| | Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin | Q28294196 |
| | RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis | Q28294501 |
| | RANKL Is Necessary and Sufficient to Initiate Development of Antigen-Sampling M Cells in the Intestinal Epithelium | Q29397534 |
| | TNF superfamily: a growing saga of kidney injury modulators. | Q30479123 |
| | Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. | Q33733718 |
| | Induction of B7-1 in podocytes is associated with nephrotic syndrome | Q33785088 |
| | Expression of parathyroid hormone-related protein in the rat glomerulus and tubule during recovery from renal ischemia | Q33910063 |
| | Imaging of the porous ultrastructure of the glomerular epithelial filtration slit | Q34457145 |
| | Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit | Q34750367 |
| | Podocyte biology and response to injury | Q35005456 |
| | Podocyte biology and the emerging understanding of podocyte diseases | Q35198433 |
| | Small RNA: can RNA interference be exploited for therapy? | Q35571567 |
| | The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. | Q51949099 |
| | Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. | Q52172979 |
| | Podocyte number predicts progression of proteinuria in IgA nephropathy. | Q53322514 |
| | Modification of kidney barrier function by the urokinase receptor. | Q53510545 |
| | RANKL Induces Organized Lymph Node Growth by Stromal Cell Proliferation | Q61051808 |
| | Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy | Q81666627 |
| | Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure | Q81730161 |
| | Membranous nephropathy | Q83254238 |
| | The role of podocytes in glomerular pathobiology | Q35623937 |
| | Ranking the role of RANK ligand in apoptosis | Q35927923 |
| | Podocyte injury and targeting therapy: an update | Q36337776 |
| | The spectrum of podocytopathies: a unifying view of glomerular diseases. | Q36780741 |
| | Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts). | Q36996103 |
| | The MIF receptor CD74 in diabetic podocyte injury | Q37086644 |
| | Inducible rodent models of acquired podocyte diseases. | Q37265903 |
| | Distinct roles for basal and induced COX-2 in podocyte injury | Q37330528 |
| | RANK ligand: effects of inhibition. | Q37738754 |
| | Targeting podocyte-associated diseases. | Q37786686 |
| | Structure and development of the glomerular capillary wall and basement membrane | Q39683135 |
| | Glial cell line-derived neurotrophic factor and its receptor ret is a novel ligand-receptor complex critical for survival response during podocyte injury | Q40284168 |
| | Enhanced Effector and Memory CTL Responses Generated by Incorporation of Receptor Activator of NF-κB (RANK)/RANK Ligand Costimulatory Molecules into Dendritic Cell Immunogens Expressing a Human Tumor-Specific Antigen | Q40628569 |
| | Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells | Q41833355 |
| | Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression | Q41998066 |
| | Suppression of nephrin expression by TNF-alpha via interfering with the cAMP-retinoic acid receptor pathway. | Q42468849 |
| | Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions. | Q43298056 |
| | RANKL regulates endothelial cell survival through the phosphatidylinositol 3′‐kinase/Akt signal transduction pathway | Q44590687 |
| | Induction of antioxidant enzymes in murine podocytes precedes injury by puromycin aminonucleoside | Q45116527 |
| | Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats. | Q45931396 |
| | 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway | Q46128806 |
| | Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury | Q46898302 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| P304 | page(s) | e41331 | |
| P577 | publication date | 2012-07-25 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Receptor activator of NF-kappaB and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury | |
| P478 | volume | 7 | |